CPT code 0335T identifies a surgical procedure that implants a synthetic device in the soft tissues between the ankle and heel bones to treat hyperpronation of the foot. As a specific, procedure-level code, it captures a targeted biomechanical intervention used to address symptomatic overpronation that may contribute to pain, instability, or progressive deformity. Nationally, precise coding for emerging or specialized foot procedures affects claims adjudication, coverage determinations, and tracking of utilization trends.

Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical intent of the procedure, typical sites of service, and which major payers are relevant to coverage and reimbursement considerations. The report summarizes available benchmarks and common payer approaches where present, notes whether policy-level guidance exists, and provides clinical context linking the procedure to indications and postoperative considerations.

This summary equips billing managers, coding professionals, and policy analysts with a clear, national-level reference for CPT code 0335T, highlighting where to focus further review for payer-specific medical necessity criteria, prior authorization requirements, and documentation best practices. Data not available in the input is identified where applicable.